
Varex Imaging Corporation: financial statements
Price
$18.10
November 20, 2026Market cap $755M
What Ploutos Investor adds for Varex Imaging
Part of Ploutos Investor, €9.99 a month
- The full history: 11 fiscal years, from FY2015
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
- The latest annual figures the company filed are for 2025, more than a year ago. Newer ones may be late.
Financial statements
Each fiscal year's income statement, balance sheet and cash flow as the company filed them, and the latest quarters.
Click a line to see it on the chart.
Revenue
-2.8% a year over 2 years
| Line | FY2023 | FY2024 | FY2025 | Average a year |
|---|---|---|---|---|
| Revenue | $893M | $811M | $845M | -2.8% |
| Cost of revenue | $603M | $554M | $554M | -4.1% |
| Gross profit | $290M | $257M | $291M | +0.0% |
| Operating income | $77M | $32M | -$28M | |
| Net income | $47M | -$49M | -$70M | |
| Earnings per share | $1.07 | -$1.20 | -$1.70 | |
| Earnings per share, basic | $1.18 | -$1.20 | -$1.70 | |
| Margins | ||||
| Gross margin | 32.5% | 31.7% | 34.4% | |
| Operating margin | 8.6% | 4.0% | -3.3% | |
| Net margin | 5.3% | -6.0% | -8.3% | |
Financial statements
VREX's revenue, profits and cash flows from FY2015 to FY2022, 8 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
By segment
Revenue and operating income by business segment or by product, as the company itself reports them in each year's 10-K. Each year from the latest filing that carries it, so a segment renamed or re-cut shows in its current form.
- Medical
- Industrial
- FY2023: Medical $673M, Industrial $220M
- FY2024: Medical $582M, Industrial $229M
- FY2025: Medical $593M, Industrial $252M
| Segment | FY2023 | FY2024 | FY2025 | Share FY2025 |
|---|---|---|---|---|
| Medical | $673M | $582M | $593M | 70% |
| Industrial | $220M | $229M | $252M | 30% |
By segment
VREX's revenue by segment from FY2015 to FY2022, 8 more fiscal years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 5 fiscal years.
From the XBRL of 9 of the company's annual reports to the SEC (ASC 280). Amounts in dollars.
Amounts are in dollars as the company filed them in its annual reports (10-K or 20-F). Those reporting in another currency are converted at each fiscal year-end rate. Shares and earnings per share are adjusted for splits.
Debt and obligations
What the company owes beyond the loans on its balance sheet, and when it pays, from the notes to its annual report: debt maturities, leases, pension plans, goodwill by segment, and how it gets to the tax it pays.
The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
When the debt falls due
Oct 3, 2025Due within 2 years
$370M
Principal of loans and bonds falling due, from the annual report dated October 3, 2025, without leases and interest. The filing
- 10/2026: $1.5M
- 10/2027: $368M
Leases
Oct 3, 2025Operating leases
$28M
Finance leases
$6.0M
The liability is the present value of the rent still to pay, at October 3, 2025. It is not counted in the ladder's debt. The filing
Goodwill by segment
Oct 3, 2025Total goodwill
$198M
- Industrial$119M60%
Goodwill is what the company paid in acquisitions above the value of what it bought, at October 3, 2025. If an acquisition earns less, the goodwill is impaired and earnings fall. Impairment in the year: $94M.The filing
From the statutory to the effective tax rate, FY2025
Oct 3, 2025Statutory rate
21.0%
Effective rate
-18.1%
The company paid -18.1% in tax on its profit, 39.1 points below the US federal rate (21.0%). Below, the reasons it gives.
The lines the company states do not reach its effective rate, so we do not show them. Both rates are the filing's. The filing
Claims ahead of shareholders
What stands between the business and its shareholders besides the debt, and the financial assets on the other side, from the latest balance sheet.
$14M of other claims rank ahead of the shares, about 1.8% of the market value.
Ahead of the shares
- at Jul 3, 2026
- $14M
From the balance sheet of July 3, 2026. The retirement and environmental lines and the pension deficit come from the latest annual report when the quarter's filing does not state them, each with its own date. Market value at the price of November 20, 2026. A line is listed when it is at least 0.5% of the market value. A description of the balance sheet, not a valuation.
Earnings quality
How the reported earnings were made, read from the filings. A description, not a score: our tests found no link between these measures and later share returns.
Receivables and inventory against sales
In the quarter to Jul 3, 2026, sales were +3.7% on the same quarter a year earlier, and receivables +5.6%. Inventory was +16.2%, against -1.3% for the cost of sales.
- a year earlier 61 days
- 62 days
- a year earlier 198 days
- 234 days
Balances at Jul 3, 2026 and Jul 4, 2025, against the sales and cost of sales of the quarter ending on each date; a fourth quarter is the fiscal year less its first nine months. Same quarter against same quarter, so the season is the same.
Taxes: deferred and paid
The deferred part was -6.5% of the tax charge in the year to Oct 3, 2025. The rows show the last 2 years.
Cash taxes paid were 163.2% of the current tax charge in the year to Oct 3, 2025.
- Deferred share, year to Oct 3, 2025-$700.0K of $11M
- -6.5%
- Deferred share, year to Sep 27, 2024$38M of $53M
- 72.1%
- $19M paid, $11M current
- 163.2%
When profit in the accounts runs ahead of taxable profit, the deferred part grows. It also moves for reasons unrelated to how earnings are booked: tax-law changes, the use of past losses, and the US rule since 2022 that spreads research costs over five years. Where the notes report it, the tax-rate bridge under Debt and obligations shows how the rate gets from the statutory one to the effective one.
The earnings per share split is not shown: it needs a profit before tax in both years, since a tax rate on a loss has no meaning as a source.
The allowance for doubtful accounts is not shown: the company does not tag it in its structured filings.
A reading is called out when it is above the 90th percentile of the same reading across the S&P 500, or, for a fall, below the 10th, as measured on 9 November 2026. Each part uses only the company's own filings.
The full analysis
What do Varex Imaging's filings show?
These are Varex Imaging's figures from its filings. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
How much revenue did VREX have in FY2025?
Varex Imaging had revenue of $845M and net income of -$70M in fiscal FY2025, a net margin of -8.3%.
How much debt does VREX have?
On October 3, 2025 Varex Imaging had total assets of $1.1B, debt of $368M and shareholders' equity of $473M.
How much free cash flow does VREX have?
In fiscal FY2025 Varex Imaging had cash from operations of $42M and spent $23M on capital expenditure, leaving $19M of free cash flow.
Where are the figures from?
From Varex Imaging Corporation's annual and quarterly reports to the SEC, read from the structured data (XBRL) it files itself.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.